Instil Bio Inc.

NASDAQ: TIL · Real-Time Price · USD
28.00
-0.25 (-0.87%)
At close: Aug 15, 2025, 3:59 PM
27.84
-0.57%
After-hours: Aug 15, 2025, 04:14 PM EDT

Instil Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.99M 3.99M 3.99M 7.67M 7.67M 7.67M 7.67M n/a n/a n/a n/a n/a n/a n/a n/a n/a 52K 94K
Cost of Revenue
3.39M 4.39M 4.89M 3.93M 3.98M 3.82M 4.87M 4.64M 6.09M 6.24M 5.99M 6.07M 4.43M 4.11M 2.75M 1.86M 1.09M 439K
Gross Profit
595K -405K -900K 3.74M 3.69M 3.85M 2.8M -4.64M -6.09M -6.24M -5.99M -6.07M -4.43M -4.11M -2.75M -1.86M -1.04M -345K
Operating Income
-94.24M -84.42M -73.54M -1.33M -44.41M -51.77M -90.54M -202.95M -192.88M -230.62M -226.46M -223.41M -209.79M -186.44M -155.56M -119.28M -83.97M -53.18M
Interest Income
5.22M 6.1M 6.99M 7.83M 8.49M 8.86M 8.87M 8.47M 7.43M 5.63M 3.65M 1.86M 605K 134K 37K 37K 15K n/a
Pretax Income
-84.51M -78.03M -74.14M -75.17M -119.58M -123.32M -156.09M -197.61M -186.77M -227.71M -225.25M -225.09M -212.16M -188.03M -156.75M -119.5M -83.1M -56.83M
Net Income
-84.51M -78.03M -74.14M -75.17M -119.58M -123.32M -155.34M -196.26M -185.06M -225.39M -223.18M -224.68M -211.46M -187.78M -156.79M -118.63M -82.89M -56.78M
Selling & General & Admin
37.34M 41.89M 44.21M 42.68M 43.91M 44.73M 46.52M 49.59M 54.64M 60.34M 62.23M 60.5M 57.47M 54.44M 48.31M 44.36M 33.26M 21.46M
Research & Development
26.47M 19.39M 21.28M 22.16M 20.65M 26.19M 39.6M 58.34M 89.51M 122.55M 141.06M 162.91M 152.31M 132M 107.25M 74.92M 50.77M 31.82M
Other Expenses
7.97M -308K 190K 1.92M -1.95M -325K -382K 917K 1.46M -205K -467K -2.3M -1.89M -857K -538K n/a n/a n/a
Operating Expenses
71.78M 60.97M 65.68M 66.76M 62.61M 69.96M 85.17M 106.98M 144.15M 182.9M 203.29M 223.41M 209.79M 186.44M 155.56M 119.28M 84.02M 53.28M
Interest Expense
4.11M 7.69M 8.58M 7.97M 7.96M 6.55M 5.21M 3.97M 2.78M 2.52M 1.88M 1.68M 869K 538K 609K 4.53M 4.53M 4.53M
Selling & Marketing Expenses
993K 993K n/a -2.03M -2.03M -2.03M -1.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
61.65M 80.06M 85.26M 74.58M 71.38M 72.94M 87.16M 107.93M 144.15M 182.9M 203.29M 223.41M 209.79M 186.44M 155.56M 119.28M 84.02M 53.28M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -742K -1.35M -1.72M -2.33M -2.07M -408K -695K -245K 39K -870K -212K -53K
Shares Outstanding (Basic)
6.6M 6.53M 6.53M 6.51M 6.5M 6.5M 6.5M 6.5M 6.5M 6.5M 6.49M 129.68M 129.37M 129.12M 128.95M 128.79M 128.74M 34.98M
Shares Outstanding (Diluted)
6.6M 6.53M 6.53M 6.51M 6.5M 6.5M 6.5M 6.5M 6.5M 6.5M 6.49M 129.68M 129.37M 129.12M 128.95M 128.79M 128.74M 34.98M
EPS (Basic)
-12.92 -11.97 -11.39 -11.56 -18.39 -18.97 -23.89 -30.19 -20.25 -17.84 -9.6 -1.74 -1.64 -1.45 -1.69 -1.75 -1.54 -1.42
EPS (Diluted)
-12.92 -11.97 -11.39 -11.56 -18.39 -18.97 -23.89 -30.19 -20.25 -17.84 -9.6 -1.74 -1.64 -1.45 -1.69 -1.75 -1.54 -1.42
EBITDA
-82.68M -71.16M -62.17M -63.52M -107.88M -113.2M -146.01M -189M -177.9M -219.39M -217.81M -218.31M -207.83M -183.92M -154M -117.94M -82.68M -52.42M
EBIT
-57.42M -70.34M -65.81M -67.45M -111.86M -117.02M -151.13M -193.89M -184.25M -225.44M -223.37M -223.95M -211.83M -188.03M -156.83M -120.01M -84.06M -53.18M
Depreciation & Amortization
2.14M 3.14M 3.63M 3.93M 3.98M 3.82M 4.87M 4.64M 6.09M 6.24M 5.99M 6.07M 4.43M 4.11M 2.75M 2.01M 1.31M 688K